Guidelines recommend that ICDs should not be implanted until after 90 days following revascularization in patients with an EF<35% and an MI. Studies have shown that no clinical benefit or detriment was derived by implantation prior to 90 days.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
March 23, 2016
March 22, 2016
This retrospective study evaluated the relationship between the timing betweenLHC and CABG and its effect on renal function in a cohort of 2371 patients at a single center. Findings included:
March 14, 2016
The Hopkins group reviewed differential outcomes in close to 800 patients who had undergone bilateral IMA revascularization during CABG. The compared configurations included:
March 13, 2016
This Belgian study prospectively analyzed the predictors of long-term mortality in a group of 107 consecutive CABG patients with an LV EF < 35%. All patients underwent preoperative Cardiac MR to assess both LV and RV EF.
March 13, 2016
The authors reviewed the Medicare database to analyze the trends in CABG surgery within this population over a 12-year period. Trends in the Medicare population included the following:
March 11, 2016
The authors provide an excellent overview of the rationale for screening all patients with a new diagnosis of cardiomyopathy for coronary artery disease. This rationale includes the following:
February 28, 2016
In this trial 2100 undergoing coronary surgery were randomized to aspirin 100mg or placebo. The primary outcome was defined as a composite of death and thrombotic complications (myocardial infarction, stroke, pulmonary embolism, renal failure or bowel infarction) at 30 days.
February 18, 2016
An Editorial suggesting that atheroma is here to stay...
February 18, 2016
The authors studied the relationship of outcomes after non-cardiac surgery to blood transfusion among over 7,300 patients. Patients with significant bleeding were excluded. Patients were stratified according to the occurence of postoperative MI and the nadir hematocrit value (20-24%, 24-27%, 27-30%). The outcome was 30-day mortality. In the no-
January 30, 2016
Outcomes of CABG for patients in cardiogenic shock after acute MI were evaluated using data from the STS Database. The study group of nearly 5,500 patients comprised 1.5% of all CABG patients during the study period. Operative mortality was 18.7%. Mechanical circulatory support use was most common in patients with more risk factors or high clinica